NCT02221375View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2008

Conditions
Healthy
Interventions
DRUG

BHT low

DRUG

BHT medium

DRUG

BHT high

DRUG

BI 54903 XX low

DRUG

BI 54903 XX medium 1

DRUG

BI 54903 XX medium 2

DRUG

BI 54903 XX high

DRUG

Ciclesonide

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02221375 - Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter